DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Phase III randomized study of sorafenib plus doxorubicin versus sorafenib in patients with advanced hepatocellular carcinoma (HCC).
Available at:
http://clinicaltrials.gov/ct2/show/NCT01015833 . Accessed January 11, 2012
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.